anidulafungin has been researched along with Intra-Abdominal Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aram, JA; Capparella, MR; Montravers, P; Sganga, G; Tawadrous, M; Wang, M; Yan, JL | 1 |
| Perlin, DS | 1 |
| Ammenouche, N; Dupont, H; Jung, B; Massias, L; Montravers, P | 1 |
3 other study(ies) available for anidulafungin and Intra-Abdominal Infections
| Article | Year |
|---|---|
Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Intraabdominal Infections; Male; Middle Aged; Prospective Studies; Surgical Wound Infection; Treatment Outcome; Young Adult | 2019 |
Echinocandin Resistance in Candida.
Topics: Anidulafungin; Antifungal Agents; Azoles; Candida; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Glucosyltransferases; Humans; Intraabdominal Infections; Lipopeptides; Micafungin; Mutation | 2015 |
Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis.
Topics: Administration, Intravenous; Aged; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Chromatography, High Pressure Liquid; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Intraabdominal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies | 2017 |